Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia : in vivo therapeutic efficacy and kelch13 molecular marker surveillance
Background:Spreading Plasmodium falciparum artemisinin drug resistance threatens global malaria public health gains. Limited data exist to define the extent of P. falciparum artemisinin resistance southeast of the Greater Mekong region in Malaysia. Methods:A clinical efficacy study of oral artesunate (total target dose 12 mg/kg) daily for 3 days was conducted in patients with uncomplicated falciparum malaria and a parasite count < 100,000/µL admitted to 3 adjacent district hospitals in Sabah, East Malaysia. On day 3 and 4 all patients were administered split dose mefloquine (total dose 25 m... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Journal article |
Erscheinungsdatum: | 2018 |
Schlagwörter: | Plasmodium Falciparum / Malaria / DRNTU::Science::Medicine |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27646928 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/10220/47453 |